<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    jbm
   </journal-id>
   <journal-title-group>
    <journal-title>
     Journal of Biosciences and Medicines
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2327-5081
   </issn>
   <issn publication-format="print">
    2327-509X
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/jbm.2024.129008
   </article-id>
   <article-id pub-id-type="publisher-id">
    jbm-135818
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Epidemiological and Clinical Profile of Children Exposed to SARS-CoV-2 at the COVID-19 Treatment Center at the ISIRO Hospital and WATSA in the Democratic Republic of the Congo
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Hilaire Lisimo
      </surname>
      <given-names>
       Abwa
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       David
      </surname>
      <given-names>
       Azako
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Michel
      </surname>
      <given-names>
       Ngbatala
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Bienvenu
      </surname>
      <given-names>
       Apenya
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jolie
      </surname>
      <given-names>
       Mambeizidra
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Julbert
      </surname>
      <given-names>
       Malangu
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Eugene
      </surname>
      <given-names>
       Kumbodimo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff3"> 
      <sup>3</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       George
      </surname>
      <given-names>
       Mutuale
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff4"> 
      <sup>4</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Herman
      </surname>
      <given-names>
       Luhavo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Jean Claude
      </surname>
      <given-names>
       Gbundu
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fiston
      </surname>
      <given-names>
       Bolanda
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       François
      </surname>
      <given-names>
       Enze
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff5"> 
      <sup>5</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Marie
      </surname>
      <given-names>
       Tasile
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Yvette Kpakpo
      </surname>
      <given-names>
       Nyange
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Nicholas
      </surname>
      <given-names>
       Katembo
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff6"> 
      <sup>6</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aClinics Universitaires Uele, Department of Pediatrics, Faculty of Medicine, University of Uele, Isiro, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aGeneral Hospital of Isiro, Isiro, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <aff id="aff3">
    <addr-line>
     aDivision Provinciale de la Santé du Haut Uélé, Isiro, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <aff id="aff4">
    <addr-line>
     aAdditional Vaccination Program for Watsa, Watsa, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <aff id="aff5">
    <addr-line>
     aCenter Hospitalier KIBALI, Durba, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <aff id="aff6">
    <addr-line>
     aHospital General of Watsa, Watsa, Democratic Republic of the Congo
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     02
    </day> 
    <month>
     09
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    12
   </volume> 
   <issue>
    09
   </issue>
   <fpage>
    73
   </fpage>
   <lpage>
    81
   </lpage>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Introduction:</b> COVID-19, an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), typically presents with mild clinical manifestations in pediatric populations. As in many other regions of the Democratic Republic of the Congo (DRC), the COVID-19 pandemic affected children in Haut-Uélé, a province bordering South Sudan and Uganda. This study aimed to describe the epidemiological profile of COVID-19 in pediatric population in this area. 
    <b>Materials and Methods:</b> This descriptive cross-sectional study was conducted over a 6-month period from August 1, 2021 to February 7, 2022. It included all patients aged 0 to 19 years with confirmed COVID-19 using RT-PCR and managed at the COVID-19 Treatment Centers (CTCO) in ISIRO and WATSA. Data were collected from patient records supplemented by the dataset from the service of Health Information System (SNIS) and the Epidemiological Surveillance Commission of the Provincial Health Division (DPS). Epidemiological and clinical profiles were analyzed. All statistical analyses were performed using SPSS software, Version 18. 
    <b>Results:</b> During the 4th wave of the pandemic, 5 out of 13 health zones in Haut-Uélé province were affected, with a total of 569 recorded cases; 45 of them were children aged 0 to 19 years (7.9%). Asymptomatic cases accounted for 33.3% (15 cases). The mean age was 9.88 ± 5.49 years, with the most affected age group being 10 - 14 years (44.45%). There was a predominance of males (73.3%), with a male-to-female sex ratio of 2.75. Half of the patients (53.3%) were from Watsa Health Zone. A seasonal peak was observed between December and January. Comorbidities were present in 10% of infected patients, and nearly half of participants were contacts of infected individuals. The primary reasons for admission were fever (66.66%), followed by rhinorrhea (57.77%) and cough (31.11%). All patients responded favorably to treatment. 
    <b>Conclusion:</b> The proportion of pediatric COVID-19 cases at the CTCO centers in Haut-Uélé was low, with adolescent males being the most affected group. More than half of the cases were asymptomatic. The most common reasons for consultation were fever, rhinorrhea, and cough.
   </abstract>
   <kwd-group> 
    <kwd>
     COVID-19
    </kwd> 
    <kwd>
      Morbidity and Mortality
    </kwd> 
    <kwd>
      Children
    </kwd> 
    <kwd>
      Haut-Uélé
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) <xref ref-type="bibr" rid="scirp.135818-1">
     [1]
    </xref>, has emerged as a global public health emergency since December 2019, owing to its rapid spread and escalating severity <xref ref-type="bibr" rid="scirp.135818-2">
     [2]
    </xref> <xref ref-type="bibr" rid="scirp.135818-3">
     [3]
    </xref>. As of July 5, 2020, a total of 11,125,245 cases and 528,204 deaths had been reported worldwide <xref ref-type="bibr" rid="scirp.135818-4">
     [4]
    </xref>. While COVID-19 presents a significant risk of mortality in adults, it results in a milder clinical course in children and adolescents with a lower mortality rate compared to adults <xref ref-type="bibr" rid="scirp.135818-5">
     [5]
    </xref>. The Omicron variant has been the predominant strain in Quebec since December 20, 2021, and due to its high transmissibility, there has been a substantial increase in pediatric COVID-19 cases. In Guinea, among 7308 patients hospitalized at the CTPI of HND, 189 (2.59%) were children aged 0 to 16 years <xref ref-type="bibr" rid="scirp.135818-6">
     [6]
    </xref>. Similarly, in the Democratic Republic of the Congo (DRC), the COVID-19 pandemic impacted children in the Haut-Uélé province, which borders South Sudan and Uganda, as of December 15, 2019. This study aimed to assess the epidemiological and clinical profiles of COVID-19 in children in this region of the DRC.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <p>We conducted a descriptive cross-sectional study from August 1, 2021, to February 7, 2022, at the COVID-19 Treatment Centers (CTCO) in ISIRO and AUNGBA. These centers served patients from the health zones of WATSA, ISIRO, PAWA, FARADJET, RUNGU, and NIANGARA, all located within the Haut-Uélé Provincial Health Division. The study included all patients aged 0 to 19 years who tested positive for COVID-19 via RT-PCR and received treatment at the designated CTCOs. Nasopharyngeal swabs were collected for RT-PCR testing. The variables of interest included age (in years), sex, geographic origin, medical history, clinical signs, RT-PCR results, COVID-19 variant, radiographic findings, treatment regimen, complications, and patient outcomes. Data were collected from patient’s records supplemented with the dataset from the service of Health Information System (SNIS) and the Epidemiological Surveillance Commission of the Provincial Health Division (DPS). Categorical variables were presented as absolute frequencies while mean ± standard deviation (median where applicable) was used for quantitative variables. All analyses were performed using SPSS (Statistical Package for the Social Sciences), Version 18.</p>
  </sec><sec id="s3">
   <title>3. Results</title>
   <p>A total of 569 patients were followed up for COVID-19 during the study period, including 45 children, representing 7.9% of cases. There was a predominance of males, accounting for 73.3% of the cases, with a male-to-female sex ratio of 2.75.</p>
   <sec id="s3_1">
    <title>3.1. Sociodemographic Characteristics of Confirmed Cases</title>
    <p>The most affected age group was 10 - 14 years, representing 44.5% of cases. The mean age was 9.88 ± 5.49 years (<xref ref-type="table" rid="table1">
      Table 1
     </xref>).</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135818-"></xref>Table 1. Group age.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">Age group</p></td> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">n</p></td> 
       <td class="custom-bottom-td acenter" width="33.34%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">0 - 4 years</p></td> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">12</p></td> 
       <td class="custom-top-td acenter" width="33.34%"><p style="text-align:center">26.7</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">5 - 9 years</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">4</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">8.89</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">10 - 14 years</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">20</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">44.5</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">15 - 19 years</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">9</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">20.0</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">45</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">100.0</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>The study population consisted of 33 males (73.3%) and 12 females (26.7%), resulting in a male-to-female sex ratio of 2.75 (<xref ref-type="table" rid="table2">
      Table 2
     </xref>).</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135818-"></xref>Table 2. According to gender.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Sex</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">n</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">Male</p></td> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">33</p></td> 
       <td class="custom-top-td acenter" width="33.34%"><p style="text-align:center">73.3</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Female</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">12</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">26.7</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">45</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">100.0</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>The majority of patients were from Watsa, comprising 53.3% of the cases, followed by Isiro, which accounted for 31.1% of the cases (<xref ref-type="table" rid="table3">
      Table 3
     </xref>).</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135818-"></xref>Table 3. The health zone of origin.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="37.78%"><p style="text-align:center">Health zone of origin</p></td> 
       <td class="custom-bottom-td acenter" width="31.11%"><p style="text-align:center">n</p></td> 
       <td class="custom-bottom-td acenter" width="31.11%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="37.78%"><p style="text-align:center">Watsa</p></td> 
       <td class="custom-top-td acenter" width="31.11%"><p style="text-align:center">24</p></td> 
       <td class="custom-top-td acenter" width="31.11%"><p style="text-align:center">53.3</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.78%"><p style="text-align:center">Isiro</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">14</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">31.1</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.78%"><p style="text-align:center">Pawa</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">4</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">9.0</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.78%"><p style="text-align:center">Rungu</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">2</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">4.4</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.78%"><p style="text-align:center">Faradje</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">2.2</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="37.78%"><p style="text-align:center">Total</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">45</p></td> 
       <td class="acenter" width="31.11%"><p style="text-align:center">100</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s3_2">
    <title>3.2. Clinic</title>
    <p>The comorbidities noted in descending order were allergic rhinitis, asthma, sickle cell anemia, HIV, epilepsy and finally malnutrition (<xref ref-type="table" rid="table4">
      Table 4
     </xref>).</p>
    <table-wrap id="table4">
     <label>
      <xref ref-type="table" rid="table4">
       Table 4
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135818-"></xref>Table 4. The comorbidity.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">Comorbidity</p></td> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">n</p></td> 
       <td class="custom-bottom-td acenter" width="33.34%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">Allergic rhinitis</p></td> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">6</p></td> 
       <td class="custom-top-td acenter" width="33.34%"><p style="text-align:center">13.33</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Asthma</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">5</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">11.11</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Sickle cell disease</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">6.66</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">HIV</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">2</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">4.44</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Epilepsy</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">2</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">4.44</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Malnutrition</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">1</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">2.22</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>More than half of the mothers were engaged in trading or farming, and 40% (18 cases) had been in contact with known COVID-19 cases. Additionally, 37.78% (17 cases) of the fathers were employed as civil servants at KIBALI GOLD Mining Company.</p>
    <p>Asymptomatic cases accounted for 33.3% (15 cases).</p>
    <p>Fever 66.6%, rhinorrhea 57.77%, followed by cough, were the most noted reasons for consultation (<xref ref-type="table" rid="table5">
      Table 5
     </xref>).</p>
    <table-wrap id="table5">
     <label>
      <xref ref-type="table" rid="table5">
       Table 5
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135818-"></xref>Table 5. The reasons for consultation.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">Reasons for consultation</p></td> 
       <td class="custom-bottom-td acenter" width="33.33%"><p style="text-align:center">n</p></td> 
       <td class="custom-bottom-td acenter" width="33.34%"><p style="text-align:center">%</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">Fever</p></td> 
       <td class="custom-top-td acenter" width="33.33%"><p style="text-align:center">30</p></td> 
       <td class="custom-top-td acenter" width="33.34%"><p style="text-align:center">66.66</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Rhinorrhea</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">26</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">57.77</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Cough</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">14</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">31.11</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Headaches</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">8</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">17.77</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Diarrhea</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">4</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">13.33</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Dysphagia</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">3</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">6.66</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="33.33%"><p style="text-align:center">Vomiting</p></td> 
       <td class="acenter" width="33.33%"><p style="text-align:center">2</p></td> 
       <td class="acenter" width="33.34%"><p style="text-align:center">4.44</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>
     <xref ref-type="bibr" rid="scirp.135818-"></xref>The Polymerase Chain Reaction (PCR) test was positive in 51.11% of participants, corresponding to 23 cases. All cases were due to the Omicron variant. There were no specific lesions in 12 patients (26%) who had the standard X-ray.</p>
    <p>All patients received treatment according to the WHO COVID-19 guidelines adopted in the DRC, which included:</p>
    <p>No complications or deaths were reported</p>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <sec id="s4_1">
    <title>4.1. Prevalence</title>
    <p>A total of 569 cases were documented, including 45 children aged 0 to 19 years, representing 7.9% of the cohort. This prevalence is higher compared to Camara et al. in Guinea (2.59%) and other studies, such as those conducted by Qiu et al. in China and Nicole le Seaux in Canada, which reported prevalence between 1.5% and 5% <xref ref-type="bibr" rid="scirp.135818-3">
      [3]
     </xref> <xref ref-type="bibr" rid="scirp.135818-6">
      [6]
     </xref> <xref ref-type="bibr" rid="scirp.135818-7">
      [7]
     </xref>.</p>
   </sec>
   <sec id="s4_2">
    <title>4.2. Age Group</title>
    <p>The Age</p>
    <p>The participants’ ages ranged from 0 to 19 years, with a mean age of 9.88 ± 5.49 years. The most prevalent age group was adolescents of 10 to 14 years old (n = 20, 44.5%). This finding contrasts with Claude-Audrey et al. in Yaoundé, who reported 50% of children aged 13 to 19 years with a mean age of 10.89 ± 7.13 years. In contrast, Camara et al. in Guinea observed a higher prevalence in the 0 - 4-year age group (38.62%). Viner et al. and Zhu et al. identified higher frequencies in the age group over 10 years. This trend is consistent with global observations by the American Academy of Pediatrics, the European Centre for Disease Prevention and Control, and INSP Québec (2021). Adolescents’ cellular physiology, which mimics adult cellular regeneration mechanisms with slower epithelial turnover, may explain these observations <xref ref-type="bibr" rid="scirp.135818-6">
      [6]
     </xref>. Additionally, children might exhibit different physiological responses compared to adults at various stages of infection. Recent studies suggest that children may have fewer ACE2 receptors, potentially limiting SARS-CoV-2 infection <xref ref-type="bibr" rid="scirp.135818-8">
      [8]
     </xref>. Furthermore, innate immunity, potentially “trained” by previous viral and bacterial infections or live vaccines such as BCG, may provide enhanced protection <xref ref-type="bibr" rid="scirp.135818-9">
      [9]
     </xref>. Cross-immunity with other coronaviruses and pre-existing respiratory infections could also be factors <xref ref-type="bibr" rid="scirp.135818-10">
      [10]
     </xref>. In contrast to other respiratory infections, such as legionella, RSV, influenza, measles, and varicella, which are generally more severe in adults, SARS-CoV-2-induced pathology might involve exaggerated immune responses, potentially differing in children.</p>
   </sec>
   <sec id="s4_3">
    <title>4.3. Sex</title>
    <p>A significant male predominance was observed among pediatric COVID-19 cases, with 73.3% of cases being male, resulting in a sex ratio of 2.75. This is comparable to the findings by Claude-Audrey et al. in Yaoundé, which reported a male predominance of 52% and a sex ratio of 1.08. In contrast, Camara et al. in Conakry found a higher proportion of females with a sex ratio of 1.52. The increased male susceptibility may be attributed to higher expression of immune system proteins and a longer half-life of antibodies in females, as suggested by other studies <xref ref-type="bibr" rid="scirp.135818-3">
      [3]
     </xref> <xref ref-type="bibr" rid="scirp.135818-6">
      [6]
     </xref>.</p>
   </sec>
   <sec id="s4_4">
    <title>4.4. Residence</title>
    <p>Half of the patients resided in the Watsa health zone, a strategic geographic area at the entry point to Haut-Uélé province. The region’s high mobility is influenced by the presence of Kibali Gold Mining, subcontracting activities, artisanal mining, and the international Duembe market, which attracts people from Uganda, South Sudan, and Congo. These factors contribute to significant movement of people and goods, increasing the risk of transmission due to close proximity and the breakdown of hygiene measures <xref ref-type="bibr" rid="scirp.135818-3">
      [3]
     </xref>-<xref ref-type="bibr" rid="scirp.135818-5">
      [5]
     </xref>.</p>
   </sec>
   <sec id="s4_5">
    <title>4.5. Contact Case</title>
    <p>More than half of the mothers were traders and farmers, with 40% (18 cases) being identified as contacts. Additionally, 37.78% (17 cases) of fathers were employed as civil servants at Kibali Gold Mining. Transmission was predominantly intra-familial, as schools were closed, and children remained at home while parents were at work. Close contacts, primarily mothers and/or fathers, were the most common sources of infection. Most studies have identified household exposure as a major risk factor for COVID-19 transmission in children <xref ref-type="bibr" rid="scirp.135818-3">
      [3]
     </xref>.</p>
   </sec>
   <sec id="s4_6">
    <title>4.6. Clinical Manifestations of COVID-19 in Children</title>
    <p>The most frequent admission reasons were fever (66.66%, 30 cases), followed by rhinorrhea (57.77%, 26 cases) and cough (31.11%, 14 cases). These findings align with observations by Mercier et al. at the University of Paris. While children typically experience milder forms of COVID-19, severe cases do occur. Clinical presentations in children can vary and may include rhinorrhea, cough, fever, dysphagia, and occasionally gastrointestinal symptoms (diarrhea and/or vomiting), non-specific rashes, and irritability. Severe adult markers, such as pneumonia with typical radiographic findings, anosmia, or acrocyanosis, are less common in children, particularly before age 10. Few young patients require oxygen therapy or intensive care, and when they do present with pneumonia, it is generally less severe <xref ref-type="bibr" rid="scirp.135818-11">
      [11]
     </xref>-<xref ref-type="bibr" rid="scirp.135818-14">
      [14]
     </xref>.</p>
   </sec>
   <sec id="s4_7">
    <title>4.7. Treatment</title>
    <p>All patients showed improvement under treatment and did not exhibit severe symptoms as outlined by the WHO COVID-19 management protocol. The relatively mild severity of COVID-19 in children is supported by epidemiological data from the United States, where, among 149,000 confirmed cases from February 12 to April 2, 2020, only 2572 (1.7%) were children under 18 years. According to a British study, higher adult mortality is linked to acute respiratory distress syndrome and multi-organ failure, with pro-inflammatory cytokine levels potentially causing more severe responses in adults compared to children <xref ref-type="bibr" rid="scirp.135818-14">
      [14]
     </xref>-<xref ref-type="bibr" rid="scirp.135818-17">
      [17]
     </xref>.</p>
   </sec>
   <sec id="s4_8">
    <title>4.8. Limitations and Strengths</title>
    <p>Limitations include low alert reporting from the community and healthcare facilities, risky behaviors, non-compliance with preventive measures, and limited resources for comprehensive testing such as complete blood counts, D-dimers, prothrombin time, and activated partial thromboplastin time. The absence of these tests in peripheral facilities poses a risk of patient loss during disruptions.</p>
   </sec>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>This study provides important insights into the impact of COVID-19 on children in resource-limited settings using data from the COVID-19 treatment centers in Isiro and Watsa. The fourth wave of the pandemic affected 5 out of 13 health zones in Haut-Uélé province, with a notable proportion of children aged 0 to 19 years (7.9%) affected from August 1, 2021 to February 7, 2022. Among the 569 confirmed cases, including both adults and children, there were 3 adult deaths. Male children were more affected than female children. Children generally exhibited fewer symptoms, lower infection rates, and reduced contagion compared to adults. Direct transmission between children or from children to adults is considered low, with most infections originating from adults. Indirect transmission via hands and objects may be more significant. No deaths were reported among children.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.135818-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shereen, M.A., Khan, S., Kazmi, A., Bashir, N. and Siddique, R. (2020) COVID-19 Infection: Emergence, Transmission, and Characteristics of Human Coronaviruses. Journal of Advanced Research, 24, 91-98. &gt;https://doi.org/10.1016/j.jare.2020.03.005 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gautret, P., Million, M., Jarrot, P., Camoin-Jau, L., Colson, P., Fenollar, F., et al. (2020) Natural History of COVID-19 and Therapeutic Options. Expert Review of Clinical Immunology, 16, 1159-1184. &gt;https://doi.org/10.1080/1744666x.2021.1847640 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Claude-Audrey, M., et al. (2022) Prevention of COVID-19 among Children in Yaoundé. Health Sciences and Diseases, 23, 62. 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     World Health Organization (2020) WHO COVID-19 Dashboard. &gt;https://data.who.int/dashboards/covid19/data 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kuhn, P., Sizun, J., Tscherning, C., Allen, A., Audeoud, F., Bouvard, C., et al. (2020) Accès et rôle des parents en néonatalogie en période d’épidémie COVID-19—Propositions du GREEN de la SFN. Perfectionnement en Pédiatrie, 3, 236-241.&gt;https://doi.org/10.1016/j.perped.2020.07.011 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Camara, E., Barry, I.K., Diallo, F.B., Diallo, M.L., Diop, M.M., Cherif, M.S., et al. (2020) Profil épidémiologique et clinique des enfants atteints de la maladie à Corona Virus (COVID-19) au Centre de Traitement des Epidémies et Prévention des Infections (CTEPI) du CHU de Donka à Conakry. Pan African Medical Journal, 37, Article 363. &gt;https://doi.org/10.11604/pamj.2020.37.363.26211 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Qiu, H., Wu, J., Hong, L., Luo, Y., Song, Q. and Chen, D. (2020) Clinical and Epidemiological Features of 36 Children with Coronavirus Disease 2019 (COVID-19) in Zhejiang, China: An Observational Cohort Study. The Lancet Infectious Diseases, 20, 689-696. &gt;https://doi.org/10.1016/s1473-3099(20)30198-5 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bunyavanich, S., Do, A. and Vicencio, A. (2020) Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. The Journal of the American Medical Association, 323, 2427-2429. &gt;https://doi.org/10.1001/jama.2020.8707 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Netea, M.G., Domínguez-Andrés, J., Barreiro, L.B., Chavakis, T., Divangahi, M., Fuchs, E., et al. (2020) Defining Trained Immunity and Its Role in Health and Disease. Nature Reviews Immunology, 20, 375-388. &gt;https://doi.org/10.1038/s41577-020-0285-6 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Grifoni, A., Weiskopf, D., Ramirez, S.I., Mateus, J., Dan, J.M., Moderbacher, C.R., et al. (2020) Targets of T Cells Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell, 181, 1489-1501.E15. &gt;https://doi.org/10.1016/j.cell.2020.05.015 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zimmermann, P. and Curtis, N. (2020) Coronavirus Infections in Children Including COVID-19. Pediatric Infectious Disease Journal, 39, 355-368. &gt;https://doi.org/10.1097/inf.0000000000002660 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., et al. (2020) Epidemiology of COVID-19 among Children in China. Pediatrics, 145, e20200702. &gt;https://doi.org/10.1542/peds.2020-0702 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Liu, W., Zhang, Q., Chen, J., Xiang, R., Song, H., Shu, S., et al. (2020) Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. New England Journal of Medicine, 382, 1370-1371. &gt;https://doi.org/10.1056/nejmc2003717 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sethuraman, N., Jeremiah, S.S. and Ryo, A. (2020) Interpreting Diagnostic Tests for Sars-Cov-2. Journal of the American Medical Association, 323, 2249-2251. &gt;https://doi.org/10.1001/jama.2020.8259 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Drouin, O., Hepburn, C.M., Farrar, D.S., Baerg, K., Chan, K., Cyr, C., et al. (2021) Caractéristiques des hospitalisations au Canada d’enfants ayant contracté une infection aiguë par le SRAS-CoV-2 en 2020. Canadian Medical Association Journal, 193, E1774-E1785. &gt;https://doi.org/10.1503/cmaj.210053-f 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Liguoro, I., Pilotto, C., Bonanni, M., Ferrari, M.E., Pusiol, A., Nocerino, A., et al. (2020) SARS-CoV-2 Infection in Children and Newborns: A Systematic Review. European Journal of Pediatrics, 179, 1029-1046. &gt;https://doi.org/10.1007/s00431-020-03684-7 
    </mixed-citation>
   </ref>
   <ref id="scirp.135818-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., et al. (2020) Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine, 382, 970-971. &gt;https://doi.org/10.1056/nejmc2001468
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>